# Evaluation of the Effectiveness of Paricalcitol Versus Cinacalcet With Low-Dose Vitamin D

> **NCT00977080** · PHASE4 · COMPLETED · sponsor: **Abbott** · enrollment: 272 (actual)

## Conditions studied

- Chronic Kidney Disease
- Secondary Hyperparathyroidism
- Hemodialysis

## Interventions

- **DRUG:** Paricalcitol
- **DRUG:** Cinacalcet

## Key facts

- **NCT ID:** NCT00977080
- **Lead sponsor:** Abbott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11
- **Primary completion:** 2011-05
- **Final completion:** 2011-05
- **Target enrollment:** 272 (ACTUAL)
- **Last updated:** 2012-06-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00977080

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00977080, "Evaluation of the Effectiveness of Paricalcitol Versus Cinacalcet With Low-Dose Vitamin D". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00977080. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*